Dr. Weg Jr. I contacted GILEAD and below is the response!
Coronavirus response GILEAD SCIENCES
Hi Andrew,
Thank you for reaching out and we understand the urgency of this matter. We have transitioned to a multi-patient expanded access program for remdesivir and information is provided here. All remdesivir requests must be made through a clinician.
Additionally, we are urging physicians to enroll patients in clinical trials. Please refer the physician to the links below for information on current clinical trials investigating the use of remdesivir in COVID-19:
NIAID study: NCT04280705
Gilead study in patients with moderate disease: NCT04292730
Gilead study in patients with severe disease: NCT04292899
INSERM study: NCT04314817
China study in patient with mild/moderate disease: NCT04252664
China study in patients with severe disease: NCT04257656
HERE’S THE APPLICATION: https://clinicaltrials.gov/ct2/show/NCT04292899
Best Regards,
Gilead Sciences
THIS IS ANDREW BENJAMIN, the sender of the request to Gilead: agbusa@gmail.com
I’ve relayed that message in its entirety, including your contact info. Many thanks.